Article citationsMore >>

Mathews T, Aderibigbe Y. Proposed research diagnostic criteria for neuroleptic malignant syndrome. The International Journal of Neuropsychopharmacology. 1999;2(2):129-144.

has been cited by the following article:

Article

Neuroleptic Malignant Syndrome and Elevated CSF Protein with Quetiapine: Case Report and Review of Literature

1Department of Medicine, All India Institute of Medical Sciences (AIIMS), New Delhi


American Journal of Medical Case Reports. 2017, Vol. 5 No. 4, 79-82
DOI: 10.12691/ajmcr-5-4-1
Copyright © 2017 Science and Education Publishing

Cite this paper:
Kartik Gupta, Sravan Dubasi, Arvind Kumar, Naveet Wig. Neuroleptic Malignant Syndrome and Elevated CSF Protein with Quetiapine: Case Report and Review of Literature. American Journal of Medical Case Reports. 2017; 5(4):79-82. doi: 10.12691/ajmcr-5-4-1.

Correspondence to: Arvind  Kumar, Naveet Wig, Department of Medicine, All India Institute of Medical Sciences (AIIMS), New Delhi. Email: naveetwig@gmail.com

Abstract

Neuroleptic malignant syndrome (NMS) is a well-known complication of dopaminergic blockade. While there have been many case reports on Quetiapine-induced NMS, cerebrospinal fluid (CSF) abnormalities have never been documented. We report this case of bipolar affective disorder who had a previous history of Risperidone-induced parkinsonian rigidity. He presented to us 20 days after increasing lithium dose and starting Quetiapine and lamotrigine for an acute episode of mania. He had coarse tremors at rest, hyperthermia, altered sensorium and elevated creatine phosphokinase (CPK). CSF analysis showed elevated protein with no cells. A provisional diagnosis NMS was made and he was given bromocriptine. Patient’s hyperthermia resolved and CPK normalized with this treatment. He was subsequently discharged and is in follow up for his bipolar disorder.

Keywords